Outcomes of active surveillance for men with intermediate-risk prostate cancer (Q34679207)

3 August 2017

Outcomes of active surveillance for men with intermediate-risk prostate cancer (English)

1 reference

3 August 2017

1 reference

Matthew R Cooperberg

1

0 references

author name string

Janet E Cowan

2

1 reference

3 August 2017

Joan F Hilton

3

1 reference

3 August 2017

Adam C Reese

4

1 reference

3 August 2017

Harras B Zaid

5

1 reference

3 August 2017

Sima P Porten

6

1 reference

3 August 2017

Katsuto Shinohara

7

1 reference

3 August 2017

Maxwell V Meng

8

1 reference

3 August 2017

Kirsten L Greene

9

1 reference

3 August 2017

Peter R Carroll

10

1 reference

3 August 2017

language of work or name

English

0 references

publication date

29 November 2010

1 reference

Journal of Clinical Oncology

3 August 2017

1 reference

3 August 2017

29

1 reference

3 August 2017

2

1 reference

3 August 2017

228-234

1 reference

3 August 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Rethinking screening for breast cancer and prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Outcomes of localized prostate cancer following conservative management

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Contemporary risk profile of prostate cancer in the United States

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Insignificant prostate cancer and active surveillance: from definition to clinical implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

An updated catalog of prostate cancer predictive tools

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Active surveillance for the management of prostate cancer in a contemporary cohort

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Active surveillance for early-stage prostate cancer: review of the current literature

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Contemporary trends in low risk prostate cancer: risk assessment and treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Active surveillance with selective delayed intervention using PSA doubling time for good risk prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

An analysis of men with clinically localized prostate cancer who deferred definitive therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Pathological outcomes of candidates for active surveillance of prostate cancer

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

The surgical learning curve for prostate cancer control after radical prostatectomy.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened P

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3058278

Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy

9 December 2018

1 reference

12 December 2020

Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a 'rapid riser' subset

1 reference

12 December 2020

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men

1 reference

12 December 2020

What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database

1 reference

12 December 2020

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

1 reference

12 December 2020

Active surveillance for early-stage prostate cancer: defining the triggers for intervention

1 reference

12 December 2020

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2010.31.4252

1 reference

3 August 2017

1 reference

3 August 2017

1 reference